10 mg · 20 mg · 30 mg · 50 mg
Retatrutide
Investigational peptide targeting GIP, GLP-1 and glucagon receptors. Studied in clinical trials on body weight and glycemic control.
For research use only
Semax
Synthetic peptide studied in neurobiology, with preclinical research on neuroprotection and inflammatory responses in cerebral ischemia.
- Pay by card (Stripe) or Zelle
- Ships within the U.S. with tracking
- Questions? Call or email us
Benefits under study
Preclinical research in rat models of cerebral ischemia.
- Experimental neuroprotection
- Inflammatory response modulation
- Neuronal recovery signaling
Research overview
Semax is a synthetic heptapeptide built from the ACTH(4–7) fragment extended with a Pro-Gly-Pro sequence, which increases its stability.
It has been studied in neurobiology research on cognitive function, neuroprotection, stress-response pathways and brain-derived neurotrophic factor (BDNF) signaling. Preclinical work in rat models of cerebral ischemia-reperfusion has examined brain protein expression related to neuroprotection, inflammation and neuronal recovery.
Supplied as a 10 mg vial for laboratory research.
Scientific references
Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion
Int J Mol Sci, 2021 · PMID 34201112
View on PubMed
You may also need
10 mg · 20 mg
Tesamorelin
GHRH analog studied in GH/IGF-1 signaling and visceral fat, including trials in people with HIV and altered fat distribution.
100 mg
KLOW
Blend of GHK-Cu, BPC-157, TB-500 and KPV. Studies on the individual components do not evaluate the blend.